Back to Authors

Pittock, Sean

A5124425581 | I2802423016

Mayo Clinic

WinnMed

Citations 14

Characterization of HLA-restricted GAD65-specific CD8+ T cell Responses in Patients with GAD65 Antibody-associated Disorders (S16.009)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217314

PDE10A-IgG Neurological Autoimmunity: Expanded Clinical Phenotypes and Immunologic Observations. (S30.003)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216640

Tocilizumab and Satralizumab in MOGAD: Real-world Outcomes for Relapse Prevention (P3-1.002)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216861

International Evaluation of the Aquaporin-4 Antibody Rapid Idot Test (LS1.005)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217918

Myelin Alterations Within and Beyond Lesions in MOG Antibody-associated Disease: Insights from Ultra-high field (7T) MRI (S6.002)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217390

Radiographic Determinants of Serum Neurofilament Light Chain Elevation in Multiple Sclerosis (P8-19.002)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216614

Calmodulin Kinase-like Vesicle-associated Protein (CAMKV) Autoimmune Encephalitis: Neurological & Oncological Accompaniments, Treatments, & Outcomes (S30.005)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216000

Effectiveness of Infliximab for Refractory Non-ischemic Cerebral Enhancing Foreign-body Granulomatous Lesions Following Endovascular Therapy (P1-1.003)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215791

Gene Expression Signatures Associated with Prior Rituximab Treatment in Patients with Anti-aquaporin-4 Antibody-positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) in the CHAMPION-NMOSD Trial (S6.007)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215648

Frequency of Optic Nerve Enhancement During Acute Optic Neuritis in MOG Antibody-associated Disease (S6.004)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215356